The University of Queensland’s BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.
F. Hoffmann-La Roche in artificial intelligence: Theme innovation strategy
Share this article F. Hoffmann-La Roche grant share with artificial intelligence as a theme is 18% in Q3 2023. Grant share is based on the